Plasmapheresis Market is anticipated to grow to $2.55 billion by 2030, with an expected compound annual growth rate (CAGR) of 8.6% from 2023 to 2030.
Meticulous Research® has published its latest insights on the global plasmapheresis market, projecting a robust expansion with an anticipated market value of $2.55 billion by 2030, at a CAGR of 8.6% from 2023 to 2030. Key factors influencing this growth include a marked rise in autoimmune diseases, increasing biopharmaceutical demand for source plasma, and supportive reimbursement policies that enhance accessibility to plasmapheresis procedures.
Request For Sample Report: https://www.meticulousresearch.com/request-sample-report/cp_id=3092
Market Growth Drivers and Opportunities
The rise in autoimmune disorders worldwide has accelerated demand for plasmapheresis, a life-saving therapeutic procedure. In tandem, the biopharmaceutical sector’s expanding need for source plasma to produce plasma-derived therapies is expected to drive market expansion significantly. Favorable reimbursement policies are further enhancing procedural accessibility, enabling healthcare providers to meet the growing patient demand.
Emerging economies are also showing a marked increase in demand for plasmapheresis services, offering significant opportunities for market expansion. However, challenges such as the high cost of plasmapheresis equipment, procedural risks, and limited awareness in certain regions may slightly temper this growth trajectory. Additionally, some regions continue to face limited access to plasmapheresis facilities, further affecting the market’s reach.
Segment Analysis
The plasmapheresis market report provides an in-depth segmentation analysis by product, technology, application, end-user, and geography, offering a clear outlook on growth trends and competitive dynamics.
- Product Segment: In 2023, disposables are expected to lead the market with the largest segment share. The demand is driven by the frequent need for disposable plasma separation filters and administration sets in plasmapheresis procedures.
- Technology Segment: Centrifugation technology, known for its efficiency in separating plasma from blood components, is projected to hold the largest market share in 2023. This technology’s rapid separation capability is especially crucial in time-sensitive clinical applications.
- Application Segment: Source plasma collection is anticipated to command the highest share within the application segment, propelled by rising demand from pharmaceutical and biotech industries and increased public awareness regarding plasma donation.
- End-User Segment: The source plasma collection sector is expected to lead the end-user market segment in 2023. This growth is attributed to the heightened need for plasma to produce plasma-derived therapies through advanced fractionation techniques.
Geographic Review
The study offers a comprehensive analysis across key regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America is projected to hold the largest market share in 2023, driven by high awareness of plasmapheresis applications, prevalent autoimmune diseases, significant technology adoption, and advanced healthcare infrastructure. Europe and Asia-Pacific follow, with Europe benefiting from a robust healthcare infrastructure and Asia-Pacific seeing increased adoption in emerging economies.
Buy Now: https://www.meticulousresearch.com/Checkout/79432394
Key Market Players
The global plasmapheresis market landscape is shaped by leading industry players, including: Asahi Kasei Corporation (Japan), Terumo Corporation (Japan), Baxter International Inc. (U.S.), B. Braun Melsungen AG (Germany), SB-Kawasumi Laboratories, Inc (Japan), Kaneka Corporation (Japan), Haemonetics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Shanghai Dahua Medical Apparatus Co., Ltd. (China), and Infomed SA (Switzerland).
Related Reports:
Contact Lens Market: https://www.meticulousresearch.com/product/contact-lens-market-5891
Neurogenomics Market: https://www.meticulousresearch.com/product/neurogenomics-market-6019
Hospital Beds Market: https://www.meticulousresearch.com/product/hospital-beds-market-5091
About the Company
We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition.
Contact:
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research